Slaoui steps down from two more biotechs after harassment claim

Moncef Slaoui, the former leader of the U.S. coronavirus vaccine program, has stepped down from leadership roles at two biotech companies after being fired by GlaxoSmithKline over accusations of sexual harassment.
One day after GSK announced Slaoui's firing as chairman of Galvani Bioelectonics, Vaxcyte and Centessa Pharmaceuticals said they have parted ways with him as well. Slaoui joined Vaxcyte's board in 2017 and became chairman a year later. Centessa launched last month with Slaoui as chief scientific officer and adviser.